CureVac
CureVac is a biotechnology company that has been acquired by and integrated into the BioNTech Group. It operates as part of a global immunotherapy organization focused on developing therapies for cancer and other serious diseases. The company contributes to the development of next-generation medical treatments within the BioNTech portfolio.
Biotechnology
Immunotherapy
Healthcare
Funding summary
- Total raised
- €581.0M
- Funding rounds
- 6
Investors in CureVac
Investors on record for CureVac. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like CureVac?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors